<rss version="2.0" xmlns:a10="http://www.w3.org/2005/Atom"><channel><title>RSC - RSC Pharm. latest articles</title><link>http://pubs.rsc.org/en/Journals/Journal/PM</link><description>RSC - RSC Pharm. latest articles</description><copyright>Copyright (c)  The Royal Society of Chemistry</copyright><lastBuildDate>Tue, 30 Jun 2026 12:02:25 Z</lastBuildDate><category>RSC - RSC Pharm. latest articles</category><image><url>http://pubs.rsc.org/content/NewImages/rsc_publishing_logo.gif</url><title>RSC - RSC Pharm. latest articles</title><link>http://pubs.rsc.org/en/Journals/Journal/PM</link></image><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00029K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00029K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00029K</link><title>PLGA and Eudragit-based long-acting microspheres for Parkinson's disease management</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6PM00029K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Pharm.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6PM00029K, Paper&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Deepa D. Nakmode, Haripriya Koppisetti, Weranga Rajapaksha, Yunmei Song, Sanjay Garg&lt;br/&gt;A long-acting PLGA/Eudragit microsphere formulation was developed to replace frequent oral dosing for Parkinson's disease. It successfully delivered hydrophilic pramipexole, achieving sustained release for up to 18 days with excellent syringeability.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-26T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Deepa D. Nakmode</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Haripriya Koppisetti</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Weranga Rajapaksha</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yunmei Song</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sanjay Garg</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00134C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00134C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00134C</link><title>Marburg self-amplifying mRNA-lipid nanoparticle vaccine: differential effects when co-formulated with Toll-like Receptor agonists</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6PM00134C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Pharm.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6PM00134C, Paper&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Mhd Anas Tomeh, Gillian Hoover, Sarah Horst, Erik de Leeuw, Murty Chengalvala, Robin Shattock, Allan Watkinson&lt;br/&gt;Schematic representation of Marburg saRNA-LNP vaccine formulations and the type of targeted receptors.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-24T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Mhd Anas Tomeh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Gillian Hoover</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sarah Horst</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Erik de Leeuw</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Murty Chengalvala</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Robin Shattock</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Allan Watkinson</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00082G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00082G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00082G</link><title>Hapten-conjugated polymeric nanocarriers produced by Flash NanoPrecipitation induce small molecule-specific antibodies in vivo</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Pharm.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6PM00082G, Paper&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Mojhdeh Baghbanbashi, Ryan Burnett, David Gooden, Frank Vago, Herman F Staats, Brandi T Johnson-Weaver, Kurt Ristroph&lt;br/&gt;Vaccines that induce antibodies specific against small molecules are desirable for a range of applications, including as a tool against the opioid epidemic. Many small molecules are not immunogenic due...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-25T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Mojhdeh Baghbanbashi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ryan Burnett</creator><creator xmlns="http://purl.org/dc/elements/1.1/">David Gooden</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Frank Vago</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Herman F Staats</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Brandi T Johnson-Weaver</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kurt Ristroph</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00162A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00162A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00162A</link><title>Nanographene Oxide Enables Activity-Preserving Immobilization and Enhanced Stability of Galactose Oxidase</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Pharm.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6PM00162A, Paper&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Junyoung  Jung, Abhishek Sahu, Giyoong Tae&lt;br/&gt;Enzyme-mediated generation of reactive oxygen species (ROS) has attracted considerable interest for cancer-related applications. However, the biomedical use of oxidase enzymes is often limited by their intrinsic instability and rapid...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-25T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Junyoung  Jung</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Abhishek Sahu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Giyoong Tae</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00126B"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00126B</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00126B</link><title>Lipid Phase Organization Controls Drug Partitioning and Release Across Lipid Nanocarriers</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Pharm.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6PM00126B, Paper&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Jader Pires, Lucas R De Souza, Bianca B Fontanezi, Sebastião Mendanha, Eliana Lima&lt;br/&gt;Understanding how lipid organization governs drug incorporation and release across nanocarrier platforms remains a central challenge in the rational design of lipid-based delivery systems. Here, lipid nanoparticles (LNP), liposomes (LIP),...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-24T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Jader Pires</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lucas R De Souza</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Bianca B Fontanezi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sebastião Mendanha</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Eliana Lima</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00129G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00129G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00129G</link><title>Dynamic vapor sorption for quality assessment of pharmaceutical coatings: a case study in enteric protection</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6PM00129G" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Pharm.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6PM00129G, Paper&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Jesús Alberto Afonso Urich, Michael Piller, Anna Sophie Neubauer, Anna Fedorko, Raymar Andreina Lara García&lt;br/&gt;Combining DVS, OCT, and acid-stage dissolution testing enables a multidimensional evaluation of enteric coatings, linking moisture permeability and coating structure to acid resistance supporting Quality by Design (QbD) principles.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-19T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Jesús Alberto Afonso Urich</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Michael Piller</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anna Sophie Neubauer</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anna Fedorko</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Raymar Andreina Lara García</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00049E"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00049E</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00049E</link><title>Development of betaine–aloe vera–gelatin hydrogel formulation for the treatment of burn wounds</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6PM00049E" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Pharm.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6PM00049E, Paper&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Rohan Dattatray Londhe, Shikha Tripathi, Obulapathi Ummadisetty, Anurag Kumar Singh, Deepak Chouhan, Avanish Singh Parmar, Vinod Tiwari&lt;br/&gt;Burn wounds present a significant clinical challenge, often leading to prolonged healing, infection, and substantial scarring.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-15T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Rohan Dattatray Londhe</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shikha Tripathi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Obulapathi Ummadisetty</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anurag Kumar Singh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Deepak Chouhan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Avanish Singh Parmar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vinod Tiwari</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00035E"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00035E</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00035E</link><title>A modelling-based comparison of IVRT and synthetic-membrane permeation for early formulation screening</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6PM00035E" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Pharm.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6PM00035E, Paper&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Yongrui Xiao, Chunlin Chen, Yu Zhang, Dimitrios Tsaoulidis, Tao Chen&lt;br/&gt;IVRT release rates (6 h, nylon membrane) correlate strongly with IVPT flux (30 h, Strat-M) across fifteen ibuprofen poloxamer-407 formulations (Pearson &lt;em&gt;r&lt;/em&gt; = 0.95, &lt;em&gt;R&lt;/em&gt;&lt;small&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/small&gt; = 0.92), supporting IVRT for early formulation screening.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-09T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Yongrui Xiao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Chunlin Chen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yu Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dimitrios Tsaoulidis</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Tao Chen</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D5PM00380F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D5PM00380F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D5PM00380F</link><title>Dual-adjuvant mucosal vaccine leveraging mast cell and TLR9 agonists for protection against poxvirus infection</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5PM00380F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Pharm.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5PM00380F, Paper&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Connor T. Murphy, Grace L. Williamson, Luis Ontiveros-Padilla, Aaron T. Hendricksen, Brandi T. Johnson-Weaver, Hae Woong Choi, David M. Gooden, Santhosh Kalpathy, Alexandra M. Lopez, Erik S. Pena, Jacob M. Bachelder, Rani S. Sellers, Soman N. Abraham, Herman F. Staats, Kristy M. Ainslie&lt;br/&gt;A novel, mast cell activating small molecule was combined with the FDA-approved adjuvant, CpG, to produce an effective dual-adjuvanted mucosal vaccine formulation for orthopoxviruses.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-04T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Connor T. Murphy</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Grace L. Williamson</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Luis Ontiveros-Padilla</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Aaron T. Hendricksen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Brandi T. Johnson-Weaver</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hae Woong Choi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">David M. Gooden</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Santhosh Kalpathy</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alexandra M. Lopez</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Erik S. Pena</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jacob M. Bachelder</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rani S. Sellers</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Soman N. Abraham</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Herman F. Staats</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kristy M. Ainslie</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00042H"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00042H</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00042H</link><title>The interplay between cationic peptide sequence, siRNA and electrolyte: formulating lipopolyplexes in NaCl solution affords nanocomplexes with exceptional levels of gene silencing</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6PM00042H" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Pharm.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6PM00042H, Paper&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Lili Cui, Laila Kudsiova, Frederick Campbell, David J. Barlow, Ann E. Terry, Yining Ma, Najet Mahmoudi, Helen C. Hailes, Alethea B. Tabor, M. Jayne Lawrence&lt;br/&gt;Formulating siRNA lipopolyplexes in NaCl solution gives large, multilamellar complexes with high levels of gene silencing in the presence of serum.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-08T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Lili Cui</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Laila Kudsiova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Frederick Campbell</creator><creator xmlns="http://purl.org/dc/elements/1.1/">David J. Barlow</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ann E. Terry</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yining Ma</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Najet Mahmoudi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Helen C. Hailes</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alethea B. Tabor</creator><creator xmlns="http://purl.org/dc/elements/1.1/">M. Jayne Lawrence</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00015K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00015K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00015K</link><title>Nanoparticle vaccine formulations for dengue virus</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6PM00015K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Pharm.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6PM00015K, Review Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Connor T. Murphy, Kristy M. Ainslie&lt;br/&gt;Dengue virus (DENV) is one of the most prevalent mosquito-borne pathogens, with almost half of the global population at risk of infection.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-02T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Connor T. Murphy</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kristy M. Ainslie</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00089D"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00089D</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/PM/D6PM00089D</link><title>Design and development of niacinamide lipid and polymeric nanoparticles and in vitro permeation studies using human epidermis</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6PM00089D" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Pharm.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6PM00089D, Paper&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Dimitra Bompou, Emanuela Di Biase, Alexandra Sarika, Efstathia Triantafyllopoulou, Natassa Pippa, Dimitrios M. Rekkas, Paraskevas P. Dallas&lt;br/&gt;Design and development of niacinamide nanoparticles using Design of Experiments.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-28T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Dimitra Bompou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Emanuela Di Biase</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alexandra Sarika</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Efstathia Triantafyllopoulou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Natassa Pippa</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dimitrios M. Rekkas</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Paraskevas P. Dallas</creator></item></channel></rss>